Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Conversation: Treatment of CML patients after failure of 2 TKIs

  Andreas Hochhaus

Expert:

Professor Andreas Hochhaus
Director of the Department of Hematology and Medical Oncology
Jena University Hospital
(Germany)

iCMLf Conversation: CML Highlights of EHA 2022 - Biological and clinical overview

Collage Hughes Wolf

Experts:

Professor Timothy Hughes
SAHMRI / SA Pathology, University of Adelaide (Australia)

Professor Dominik Wolf
Department of Hematology and Oncology, Comprehensive Cancer Centre, Medical University Innsbruck (Austria)

iCMLf Conversation: Update on CML and COVID-19 management (in Spanish)

 

 


 Experts:

Collage Pavlovsky Moiraghi

 

  • Dr Carolina Pavlovsky, Fundaleu Hospital and Clinical Research Center Buenos Aires (Argentina)

  • Dr Beatriz Moiraghi, Hospital Ramos Mejía, Buenos Aires (Argentina)

iCMLf Conversation: Update on CML and COVID-19 management (in Portuguese)

 

 


 Experts:

Pagnano Boquimpani Toreli II

  • Dra Katia Pagnano – Hemocentro -Unicamp, Campinas, SP (Brasil)

  • Dra Carla Boquimpani – Hemorio, Rio de Janeiro (Brasil)

  • Dra Ana Carolina Toreli - Hemocentro-Unicamp;
    Santa Casa São José dos Campos, São Paulo (Brasil)

iCMLf Conversation: Update on CML and COVID-19 management (in Russian)

  EHA 2018 Lomaia

Expert:

Dr Elza Lomaia
Almazov National Medical Research Centre,
St Petersburg (Russian Federation)